News Release

<< Back

SurModics to Present at the CapStone Investments Small-Cap Investor Conference

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--June 10, 2008--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that it will make a presentation to the investment community at the CapStone Investments Small-Cap Investor Conference, held June 17-18 in Milwaukee, WI.

Phil Ankeny, Senior Vice President and Chief Financial Officer is scheduled to present an overview of the company and its growth strategies on Tuesday, June 17 at 12:30 p.m. (ET).

Interested parties may access a live webcast of the presentation by logging on to the Investors section of the SurModics website at www.surmodics.com. Investors are advised to visit the site at least 10 minutes before the scheduled presentation to register, download and install any necessary multimedia streaming software. The software plug-ins required for the live event can be either RealPlayer or Windows Media Player. The audio file of this webcast will be archived and available on the company's site for 30 days.

About SurModics, Inc.

SurModics, Inc. is a leading provider of surface modification and drug delivery technologies to the healthcare industry. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved patient outcomes. Core offerings include: drug delivery technologies (coatings, microparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. Collaborative efforts include a sustained drug delivery system in human trials for treatment of retinal disease and the drug delivery polymer matrix on the first-to-market drug-eluting coronary stent. SurModics is headquartered in Eden Prairie, Minnesota and its Brookwood Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the company, visit www.surmodics.com. The content of SurModics' website is not part of this release or part of any filings the company makes with the SEC.

CONTACT: SurModics, Inc.
Phil Ankeny, SVP and Chief Financial Officer
(952) 829-2700

SOURCE: SurModics, Inc.